Celtic Resources Holdings PLC
26 July 2007
Celtic Resources Holdings Plc
("Celtic Resources" or "the Company")
Purchase of remaining 25% of Zherek Gold Mine
Celtic Resources is pleased to announce that it has purchased the remaining 25%
of Zherek LLP for US$660,000 cash to take its ownership to 100%. The purchase
of the additional 25% in Zherek increases Celtic's total attributable gold
resources by approximately 210,000 ounces gold to 4.23 million ounces gold.
The 100% ownership of Zherek enables Celtic to develop Zherek as an integral
part of the Company's plans to consistently produce more than 100,000 oz/year
from their two Kazakhstan gold mines. Celtic's Suzdal and Zherek gold mines,
separated by only 28km, can take advantage of their close proximity with the
treatment of the refractory components of the Zherek ore in the fully
functioning Suzdal BIOX plant.
As of 1st January, 2006, Zherek had Measured, Indicated and Inferred sulphide
ore resources of 5.43 million tonnes at 4.8 g/t gold containing 841,000 ounces*.
In 2006, gold production from the open pit and heap leach operation on oxide
ores at Zherek was 9,735 oz, compared to 17,406 oz in 2005 as transitional ores
were encountered and recoveries and grades declined. Expected production in 2007
is 10,000 ounces.
Celtic is currently evaluating methods to treat the transitional ores in 2008
and the sulphide ores in 2009 and expects the heap leaching of oxide ores to
continue into 2008.
Kevin Foo, Managing Director, commented, "Now we have 100% ownership of Zherek,
we can focus on the next stage of planning to treat the substantial sulphide
ores in 2009, once the oxide ores are depleted. Test work and feasibility
studies continue and we expect to have a decision on Zherek's optimum
development route in early 2008."
For further information please contact:
Kevin Foo / Jonathan Scott-Barrett Jane Stacey / Leesa Peters
Celtic Resources Holdings Plc Conduit PR
Tel: + 44 (0)20 7921 8800 Tel: +44 (0)20 7429 6606 / (0)792 292 3306
Investors@celticresources.com jane@conduitpr.com
Simon Raggett / Braden Saunders Peter Krens
Strand Partners Limited Mirabaud Securities Limited
Tel: +44 (0) 20 7409 3494 Tel: +44 (0)20 7878 3362
www.celticresources.com
* Information extracted from an independent report prepared by SRK Consulting
(UK) Ltd (SRK) which was prepared under the direction of Dr. Mike Armitage,
CEng, CGeol. Dr Mike Armitage is a full time employee, and the Managing
Director, of SRK and a Member of the Institute of Materials, Metals and Mining
(IMMM) which is a Recognised Overseas Professional Organisation (ROPO) included
in a list promulgated by the Australian Stock Exchange from time to time. Dr
Mike Armitage has sufficient experience which is relevant to the style of
mineralisation and type of deposit under consideration and to the activity which
he is undertaking to qualify as a competent Person as defined in the 2004
Edition of the Australasian Code for Reporting of Exploration Results, Mineral
Resources and Ore Reserves. Dr Mike Armitage consents to the inclusion in the
report of the matters based on his information.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.